To hear about similar clinical trials, please enter your email below
Trial Title:
Rehabilitation on Equal Terms - The ReMig Study
NCT ID:
NCT05689398
Condition:
Breast Cancer
Breast Neoplasms
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Rehabilitation
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
The ReMig-study aims to increase knowledge about rehabilitation needs, the rehabilitation
process of arabic-speaking migrated women with BC, to increase the prerequisites for
optimized and equal cancer care. The study aims to map migrated Arabic-speaking women's
breast cancer rehabilitation with a focus on mental and physical recovery, lifestyle
habits as well as satisfaction and goals with the rehabilitation and compare these
outcomes with the outcomes of Swedish-speaking women. Further aim is to explore migrated
Arabic-speaking women´s experiences and attitudes towards breast cancer rehabilitation.
Detailed description:
Annually, over 2 million women are diagnosed with breast cancer (BC) globally, of which
about 8300 in Sweden. Today, 20% of the Swedish population is foreign born and previous
research has shown that women who have migrated are particularly vulnerable when
diagnosed with BC. Research focusing on migrated women is sparse as they are often
excluded from research, but available research shows that experience and management of BC
differs depending on ethnicity, that the women to a lesser extent participate in BC
screening and rehabilitation and that they have a higher mortality than Swedish born
women. In recent years, measures to promote early BC diagnosis have been initiated, but
knowledge of how optimized rehabilitation should be ensured to promote recovery and
reduce the socioeconomic burden is lacking.
This study aims to map the rehabilitation of migrant Arabic-speaking women with a focus
on mental and physical recovery, lifestyle habits and satisfaction and goals with the
rehabilitation in the first year after BC diagnosis and compare these outcomes with
Swedish-speaking women. Further to elucidate migrated Arabic-speaking women´s experiences
and attitudes towards breast cancer rehabilitation.
Criteria for eligibility:
Study pop:
Participants are planned to be recruited at breast cancer clinics in southern Sweden. The
selection is coming to consist of Arabic-speaking women, ≤18 years of age who have
migrated to Sweden and who have been diagnosed with BC (N=140). To this data comes a
matched sample with data for Swedish-speaking women from the ReScreen study (dnr 201/505)
to be used as a basis for the comparative analyses.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Undergone treatment for primary breast cancer
- ≤18 years old
- Ability to communicate in the Arabic language
- Written informed consent
Exclusion Criteria:
- Recurrent disease
- Palliative diagnosis
- Pregnancy
- Prior history of breast cancer
- Inability to participate in the study due to cognitive impairment
Gender:
Female
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Lund University, Skåne university hospital, Helsingborgs sjukhus
Address:
City:
Lund
Zip:
221 00
Country:
Sweden
Status:
Recruiting
Contact:
Last name:
Marlene Malmström, Phd
Phone:
+4646175950
Email:
marlene.malmstrom@skane.se
Investigator:
Last name:
Annette EW Holst-Hansson, PhD
Email:
Principal Investigator
Start date:
May 24, 2023
Completion date:
May 15, 2025
Lead sponsor:
Agency:
Lund University
Agency class:
Other
Source:
Lund University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05689398